Has Umar Rahman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $604 in general payments to Umar Rahman, MD across 33 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Umar Rahman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Umar Rahman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Umar Rahman, MD

Psychiatry · Silver Spring, MDNPI 1376633321

Payments from drug & device makers

$604in general payments, 2019–2025

Across 33 payments — averaging $18.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sunovion Pharmaceuticals Inc.$200
Teva Pharmaceuticals USA, Inc.$99
Alkermes, Inc.$89
Acadia Pharmaceuticals Inc$68
Johnson & Johnson$45
AbbVie$37
plus $67 from 2 others

What the payments were for

Food & beverage$604100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sunovion Pharmaceuticals Inc.	12	$200
Teva Pharmaceuticals USA, Inc.	6	$99
Alkermes, Inc.	4	$89
Acadia Pharmaceuticals Inc	3	$68
Johnson & Johnson	2	$45
AbbVie(2 entities)	2	$37
Otsuka America Pharmaceutical, Inc.	2	$35
Lundbeck LLC	2	$32

How this compares

$604 in reported general payments places this provider in the 70th percentile of 851 psychiatry providers in Maryland.

See all psychiatry providers in Maryland →

Medicare billing

Part B allowed, 2024

$180,551

Medicare patients

1,208

Services billed

1,709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Divalproex Sodium	215	$21,882
Lamotrigine OdtLamotrigine	21	$4,742
Oxcarbazepine	63	$3,259
Aripiprazole	33	$1,294
Quetiapine Fumarate	100	$1,115
Olanzapine	21	$1,070
Mirtazapine	35	$737
Trazodone Hcl	87	$716
Buspirone Hcl	34	$698
Paroxetine Hcl	42	$605
Sertraline Hcl	55	$552
Haloperidol	23	$518
Fluoxetine Hcl	39	$419
Escitalopram Oxalate	32	$372
Risperidone	37	$358

Paid to pharmacies, not to this prescriber.

Other psychiatry in Silver Spring

Michael MorseSilver Spring$16K
Elia Acevedo DiazGaithersburg$15.8M
Akira SawaBaltimore$5.1M
John VaethBaltimore$2.1M
Paul RosenbergBaltimore$1.9M
Scott AaronsonBaltimore$1.3M
Karen AndersonBaltimore$1.1M
Constantine LyketsosBaltimore$1.1M
Alan JonasBaltimore$1.1M
Sarah HertsBaltimore$1M

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →